ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
희소 세포 분리 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 12.8%로 40억 6,000만 달러로 성장합니다. 예측 기간 중의 성장은 액체생검 기반 진단의 급증, 정밀 종양학 프로그램의 확대, 순환 종양 세포 분석 증가, 비침습적 검사에 대한 수요 증가, 세포치료제 개발에서의 적용 확대 등에 기인하는 것으로 보입니다. 이 기간 중 예상되는 주요 동향으로는 3D 마이크로플루이딕스 분리 시스템, 세포 생존율 유지를 위한 온화한 분리 기술, 통합 다운스트림 분석 플랫폼, 희귀세포 분리에 AI 및 머신러닝 활용, POC(Point-Of-Care) 희귀세포 분리 장치 개발 등이 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 수년간 희귀 세포 분리 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전적 체질, 라이프스타일, 환경에 따라 치료와 케어를 맞춤화하는 의료 접근법입니다. 이러한 수요 증가의 배경에는 유전체 기술의 발전으로 인해 유전자 검사가 더 빠르고 비용 효율적으로 이루어지고 의료 서비스 프로바이더가 특정 유전자 변이를 감지할 수 있게 되었기 때문입니다. 희귀 세포 분리는 환자의 순환 종양 세포, 태아 세포, 면역 세포의 상세한 분석을 가능하게 함으로써 맞춤형 의료를 촉진하고 임상의가 이들 세포의 고유한 분자 및 유전적 특성에 맞는 치료 계획을 세울 수 있도록 돕습니다. 예를 들어 2024년 2월 미국의 전문가 회원 조직인 개인맞춤형 의약품 연합(Personalized Medicine Coalition)은 미국 식품의약국(FDA)이 2023년 새로 승인한 개인맞춤형 의약품은 16개 품목으로 2022년 6개 품목보다 증가했다고 보고했습니다. 따라서 맞춤형 의료에 대한 수요 증가가 희귀 세포 분리 시장을 발전시키고 있습니다.
희귀 세포 분리 시장의 주요 기업은 암 진단 및 맞춤 의료에서 희귀 세포 검출의 정확성, 효율성, 확장성을 향상시키기 위해 희귀 세포 및 순환 종양 세포의 열거와 같은 기술 발전에 집중하고 있습니다. 희소세포-순환종양세포 계방법은 혈액이나 기타 시료에서 암세포를 포함한 희소세포를 식별하고 계수하여 질병 모니터링 및 연구에 도움을 줍니다. 예를 들어 2024년 3월 미국 생명과학 기업 바이오 래드 랩(Bio-Rad Laboratories)은 희귀 세포 및 순환 종양 세포를 계수하기 위한 혁신적인 솔루션인 셀셀렉트 슬라이드 검증 항체(Cellselect Slides Validated Antibodies)를 발표했습니다. 본 제품은 셀셀렉트 슬라이드에 최적화된 검증된 항체 패널을 갖추고 있으며, 안정적인 염색 품질과 희귀 세포 포획을 위한 셀셀렉트 플랫폼과의 완벽한 호환성을 보장합니다. 이 제품은 고함량 이미징, 표준화된 열거, 유연한 패널 설계를 지원하여 암 연구 및 액체생검 워크플로우의 응용을 강화합니다. 이러한 발전은 분석 개발 시간을 단축하고 다운스트림 단일 세포 분석 워크플로우의 신뢰성을 향상시켜 희귀 세포 분석을 간소화할 수 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 희소 세포 분리 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 희소 세포 분리 시장 : 성장률 분석
세계의 희소 세포 분리 시장 실적 : 규모와 성장, 2019-2024
세계의 희소 세포 분리 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 희소 세포 분리 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 희소 세포 분리 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
시약과 키트
기기
세계의 희소 세포 분리 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
자기 비즈 분리
형광 활성화 세포 선별
마이크로플루이딕스 기반 기술
세계의 희소 세포 분리 시장 : 세포 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
순환종양세포
줄기세포
태아 세포
희소 면역 세포
순환 내피 세포
기타 세포 유형
세계의 희소 세포 분리 시장 : 서브 세분화, 시약과 키트(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
항체와 자기 비즈
마이크로플루이딕 시약
밀도 구배 매체
세포 분리 버퍼
염색 및 표지 시약
핵산 분리 키트
소모품
세계의 희소 세포 분리 시장 : 서브 세분화, 기기의 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
자기 활성화 세포 선별(MACS) 시스템
형광 활성화 세포 선별(FACS) 기기
마이크로플루이딕 기반 세포 분리 디바이스
하이스루풋(High throughput) 세포 선별기
자동 세포 분석기
세포 분리용 원심분리기
유전영동 기반 기기
제7장 지역별·국가별 분석
세계의 희소 세포 분리 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 희소 세포 분리 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
희소 세포 분리 시장 : 경쟁 구도
희소 세포 분리 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Corning Incorporated
Lonza Group AG
Terumo BCT Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
PerkinElmer Inc.
Bio-Techne Corporation
STEMCELL Technologies Inc.
Miltenyi Biotec B.V. & Co KG
Izon Science Limited
RareCyte Inc.
Akadeum Life Sciences Inc.
NanoCellect Biomedical Inc.
CELLENION SASU
Applied Cells Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
희소 세포 분리 시장 2029 : 새로운 기회를 제공하는 국가
희소 세포 분리 시장 2029 : 새로운 기회를 제공하는 부문
희소 세포 분리 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Rare cell isolation is the process of separating and enriching specific low-abundance cell populations, such as circulating tumor cells (CTCs) or fetal cells, from a heterogeneous mixture of cells in a sample. This process employs physical, biological, or microfluidic techniques to facilitate the detection, analysis, and characterization of these rare cells for applications in diagnostics, personalized medicine, and research.
The primary products of rare cell isolation include reagents and kits, as well as instruments. Reagents and kits consist of the chemical and biological components used during the rare cell isolation process. These utilize various technologies, such as magnetic bead separation, fluorescence-activated cell sorting, and microfluidics-based methods, and are designed for several cell types, including circulating tumor cells, stem cells, and fetal cells.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The rare cell isolation market research report is one of a series of new reports from The Business Research Company that provides rare cell isolation market statistics, including rare cell isolation industry global market size, regional shares, competitors with a rare cell isolation market share, rare cell isolation market segments, market trends and opportunities, and any further data you may need to thrive in the rare cell isolation industry. This rare cell isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rare cell isolation market size has grown rapidly in recent years. It will grow from $2.22 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth observed during the historic period can be attributed to the early adoption of cancer research applications, increased investment in academic life science research, initial advancements in immunomagnetic separation, rising demand for prenatal genetic testing, and the emergence of stem cell research in healthcare.
The rare cell isolation market size is expected to see rapid growth in the next few years. It will grow to $4.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth during the forecast period can be attributed to a surge in liquid biopsy-based diagnostics, expansion of precision oncology programs, increased analysis of circulating tumor cells, rising demand for non-invasive testing, and growing applications in cell therapy development. Major trends expected in this period include 3D microfluidic isolation systems, gentle isolation techniques to maintain cell viability, integrated downstream analysis platforms, the use of AI and machine learning in rare cell isolation, and the development of point-of-care rare cell isolation devices.
The increasing demand for personalized medicine is expected to drive growth in the rare cell isolation market in the coming years. Personalized medicine is a medical approach that customizes treatment and care based on an individual's genetic makeup, lifestyle, and environment. This rising demand is fueled by advancements in genomic technologies, which have made genetic testing faster and more cost-effective, enabling healthcare providers to detect specific genetic mutations. Rare cell isolation facilitates personalized medicine by allowing detailed analysis of a patient's circulating tumor cells, fetal cells, or immune cells, helping clinicians develop treatment plans tailored to the unique molecular and genetic characteristics of these cells. For example, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, up from 6 in 2022. Hence, the growing demand for personalized medicine is propelling the rare cell isolation market forward.
Key players in the rare cell isolation market are concentrating on technological advancements like rare cell and circulating tumor cell enumeration to improve the accuracy, efficiency, and scalability of rare cell detection in cancer diagnostics and personalized medicine. Rare cell and circulating tumor cell enumeration involves identifying and counting rare cells, including cancer cells, in blood or other samples to aid in disease monitoring and research. For instance, in March 2024, Bio-Rad Laboratories, a US-based life sciences company, introduced Celselect Slides Validated Antibodies, an innovative solution for enumerating rare cells and circulating tumor cells. This product features pre-validated antibody panels optimized for use with Celselect Slides, ensuring consistent staining quality and full compatibility with the Celselect platform for rare cell capture. It supports high-content imaging, standardized enumeration, and flexible panel design, enhancing applications in cancer research and liquid biopsy workflows. This advancement simplifies rare cell analysis by reducing assay development time and improving reliability in downstream single-cell analysis workflows.
In July 2022, Bio-Techne Corporation, a US-based biotechnology firm, acquired Namocell, Inc. for an undisclosed amount. This acquisition aims to enhance Bio-Techne's single-cell analysis and gene therapy workflow solutions by incorporating Namocell's innovative microfluidic-based single-cell sorting and dispensing technologies into its portfolio. Namocell, Inc., also US-based, specializes in single-cell sorting and dispensing platforms used in rare-cell isolation and cell line development.
Major players in the rare cell isolation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA , GE Healthcare Technologies Inc., Corning Incorporated, Lonza Group AG, Terumo BCT Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc. , Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co KG, Izon Science Limited, RareCyte Inc., Akadeum Life Sciences Inc., NanoCellect Biomedical Inc., CELLENION SASU, Applied Cells Inc.
North America was the largest region in the rare cell isolation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rare cell isolation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the rare cell isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rare cell isolation market consists of sales of microfluidic devices, immunomagnetic separation kits, dielectrophoretic systems, cell separation reagents and automated rare cell isolation platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rare Cell Isolation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rare cell isolation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rare cell isolation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare cell isolation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Reagents And Kits; Instruments
2) By Technology: Magnetic Bead Separation; Fluorescence-Activated Cell Sorting
1) By Reagents And Kits: Antibodies And Magnetic Beads; Microfluidic Reagents; Density Gradient Media; Cell Separation Buffers; Staining And Labeling Reagents; Nucleic Acid Isolation Kits; Consumables
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Rare Cell Isolation Market Characteristics
3. Rare Cell Isolation Market Trends And Strategies
4. Rare Cell Isolation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Rare Cell Isolation Growth Analysis And Strategic Analysis Framework
5.1. Global Rare Cell Isolation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Rare Cell Isolation Market Growth Rate Analysis
5.4. Global Rare Cell Isolation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Rare Cell Isolation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Rare Cell Isolation Total Addressable Market (TAM)
6. Rare Cell Isolation Market Segmentation
6.1. Global Rare Cell Isolation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
Instruments
6.2. Global Rare Cell Isolation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnetic Bead Separation
Fluorescence-Activated Cell Sorting
Microfluidics-Based Techniques
6.3. Global Rare Cell Isolation Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Circulating Tumor Cells
Stem Cells
Fetal Cells
Rare Immune Cells
Circulating Endothelial Cells
Other Cell Types
6.4. Global Rare Cell Isolation Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibodies And Magnetic Beads
Microfluidic Reagents
Density Gradient Media
Cell Separation Buffers
Staining And Labeling Reagents
Nucleic Acid Isolation Kits
Consumables
6.5. Global Rare Cell Isolation Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
